Global Burden of Pediatric Respiratory Illness and the Implications for Management and Prevention

Pediatric Pulmonology

Volumn 36, Issue 6, 2003, Pages 457-461

  Zar, Heather J ^a,c   Mulholland, Kim ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PALIVIZUMAB; PNEUMOCOCCUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RETINOL; THEOPHYLLINE;

ANTIBIOTIC THERAPY; ASTHMA; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; DIET SUPPLEMENTATION; HAEMOPHILUS INFLUENZAE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION CONTROL; LUNG TUBERCULOSIS; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RETINOL DEFICIENCY; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

CHILD, PRESCHOOL; COST OF ILLNESS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; PEDIATRICS; PREVENTIVE MEDICINE; RESPIRATORY TRACT DISEASES; WORLD HEALTH;

EID: 0346328372     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10345     Document Type: Conference Paper

References (49)

1. International Conference on Acute Respiratory Infections. Acute respiratory infections: the forgotten pandemic. Communique from the International Conference on Acute Respiratory Infections held in Canberra Australia, 7-10 July 1997. Int J Tuberc Lung Dis 1998;2:2-4.
2. Campbell H. Acute respiratory infection: a global challenge. Arch Dis Child 1995;73:2861-2863.
3. Leowski J. Mortality from acute respiratory infections in children under 5 years of age: global estimates. World Health Stat Q 1986;39:139-144.
4. Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 1992;45:180-191.
5. Mulholland K. Magnitude of the problem of childhood pneumonia. Lancet 1999;354:590-592.
6. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002;2:25-32.
7. UNAIDS. Report on the global HIV/AIDS epidemic: June 2000 (document UNAIDS/00.13E). Geneva: WHO; 2000.
8. Graham SM, Coulter JBS, Gilks CF. Pulmonary disease in HIV-infected African children. Int J Tuberc Lung Dis 2001;5:12-23.
9. Tupasi TE, de Leon LE, Lupisan S, et al. Patterns of acute respiratory tract infection in children: a longitudinal study in a depressed community in Metro Manila. Rev Infect Dis 1990;12:490-499.
10. Garly ML, Aaby P. The challenge of improving the efficacy of measles vaccine. Acta Trop (Basel) 2003;85:1-17.
11. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986;5:247-251.
12. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis 1991;13:454-462.
13. Adegbola RA, Obaro SK. Diagnosis of childhood pneumonia in the tropics. Ann Trop Med Parasitol 2000;94:197-207.
14. Weber MW, Mulholland EK, Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health 1998;3:268-280.
15. Greenough A. Respiratory syncytial virus infection: clinical features, management and prophylaxis. Curr Opin Pulmon Med 2002;8:214-217.
16. Girard DZ. Which strategy for pertussis vaccination today? Paediatr Drugs 2002;4:299-313.
17. World Health Organization. Global TB control - WHO report 2001. WHO/CDS/TB/2001.287. Geneva: World Health Organization; 2001.
18. ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. ISAAC. Lancet 1998;351:1225-1232.
19. Clements CJ, Griffiths E. The global impact of vaccines containing aluminium adjuvants. Vaccine [Suppl] 2002;20:24-33.
20. Heininger U. Pertussis: an old disease that is still with us. Curr Opin Infect Dis 2001;14:329-333.
21. Zar HJ, Hanslo D, Tannenbaum E, Apolles P, Eley B, Klein M, Argent A, Burgess J, Magnus K, Bateman ED, Hussey G. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr 2001;90:119-125.
22. Van Niekerk CH, Weinberg EG, Shore SC, Heese HdeV, Van Schalkwyk DJ. Prevalence of asthma: a comparative study of urban and rural Xhosa children. Clin Allergy 1979;9:319-324.
23. Addo Yobo EOD, Custovic A, Taggart SCO, Asafo-Agyei AP, Woodcock A. Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren. Thorax 1997;52:161-165.
24. Ng'ang'a LW, Odhiambo JA, Mungai MW, Gicheha CM, Nderitu P, Maingi B, Macklem PT, Becklacke M. Prevalence of exercise induced bronchospasm in Kenyan school children: an urban-rural comparison. Thorax 1998;53:919-926.
25. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis." Thorax [Suppl] 2000;55:2-10.
26. World Bank. World development indicators 2002, population dynamics. 2002; p 48-51.
27. Kneyber MC, Kimpen JL. Current concepts on active immunization against respiratory syncytial virus for infants and young children. Pediatr Infect Dis J 2002;21:685-696.
28. Perera BJ. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. Arch Dis Child 1995;72:312-316.
29. Parry H. Treating asthma in developing countries: a problem of inaccessible unavailable essential medication. Thorax 1997;52:589.
30. Watson JP, Lewis RA. Is asthma treatment affordable in developing countries? Thorax 1997;52:605-607.
31. Benatar SR. Respiratory health in a globalizing world. Am J Respir Crit Care Med 2001;163:1064-1067.
32. World Health Organization. The world health report 1999: making a difference. Geneva: World Health Organization; 1999.
33. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002;359:2097-2104.
34. Iglehart J. American health services: expenditures. N Engl J Med 1999;340:70-77.
35. Chen BH, Hong CJ, Pandey MR, Smith KR. Indoor air pollution in developing countries. World Health Stat Q 1990;43:127-138.
36. Smith KR, Samet JM, Romieu I, Bruce N. Indoor air pollution in developing countries and acute lower respiratory infections in children. Thorax 2000;55:518-532.
37. UNICEF. The state of the world's children 2001. New York: UNICEF; 2001.
38. WHO/UNICEF/The World Bank. State of the world's vaccines and immunization. UNICEF, 2002.
39. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethevenaux C, Greenwood B. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-1197.
40. Kyaw MH, Jones IG, Campbell H. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health. Acta Paediatr 2001;90:473-476.
41. Klugman KP. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis 2001;1:85-91.
42. Neuzil KM, Edwards KM. Influenza vaccines in children. Semin Pediatr Infect Dis 2002;13:174-181.
43. Committee on Infectious Diseases, American Academy of Pediatrics. Reduction of the influenza burden in children. Pediatrics 2002;110:1246-1252.
44. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow-up study in Guinea-Bissau, West Africa. Br Med J [Clin Res] 2000;321:1435-1439.
45. Paes BA. Current strategies in the prevention of respiratory syncytial virus disease. Paediatr Respir Rev 2003;4:21-27.
46. Vitamin A and Pneumonia Working Group. Potential interventions for the prevention of childhood pneumonia in developing countries: a meta-analysis of data from field trials to assess the impact of vitamin A supplementation on pneumonia morbidity and mortality. Bull WHO 1995;73:609-619.
47. Kirkwood BR, Gove S, Rogers S, Lob-Levy J, Arthur P, Campbell H. Potential interventions for the prevention of childhood pneumonia: a systematic review. Bull WHO 1995;6:793-798.
48. Sazawal S, Black RE. Meta-analysis of intervention trials on case management of pneumonia in community settings. Lancet 1992;340:528-533.
49. Lambrechts T, Bryce J, Orinda V. Integrated Management of Childhood Illness: a summary of first experiences. Bull WHO 1999;77:582-594.